| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 23, 2026 | Sell(S) | 4K | $46.78 | $173K | 16K |
| Mar 20, 2026 | Option exercise(M) | 6K | — | — | 19K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 20, 2026 | Option exercise(M) | 6K | — | — | 13K |
| Mar 20, 2026 | Grant(A) | 38K | — | $0 | 38K |
| Mar 20, 2026 | Grant(A) | 28K | — | $0 | 28K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-122268) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for CRISPR Therapeutics AG
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.